170 related articles for article (PubMed ID: 24451804)
21. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway.
Büttner A; Seifert K; Cottin T; Sarli V; Tzagkaroulaki L; Scholz S; Giannis A
Bioorg Med Chem; 2009 Jul; 17(14):4943-54. PubMed ID: 19541490
[TBL] [Abstract][Full Text] [Related]
23. A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened.
Liu YB; He LM; Sun M; Luo WJ; Lin ZC; Qiu ZP; Zhang YL; Hu A; Luo J; Qiu WW; Song BL
Cell Chem Biol; 2024 Feb; ():. PubMed ID: 38442710
[TBL] [Abstract][Full Text] [Related]
24. Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease.
Sigafoos AN; Paradise BD; Fernandez-Zapico ME
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298625
[TBL] [Abstract][Full Text] [Related]
25. Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma.
Tampa M; Georgescu SR; Mitran CI; Mitran MI; Matei C; Scheau C; Constantin C; Neagu M
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32961989
[TBL] [Abstract][Full Text] [Related]
26. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.
Di Magno L; Coni S; Di Marcotullio L; Canettieri G
Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084
[TBL] [Abstract][Full Text] [Related]
27. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.
Chaudary N; Pintilie M; Hedley D; Fyles AW; Milosevic M; Clarke B; Hill RP; Mackay H
Cancer; 2012 Jun; 118(12):3105-15. PubMed ID: 22028038
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Hedgehog pathway in cancer.
Gupta S; Takebe N; Lorusso P
Ther Adv Med Oncol; 2010 Jul; 2(4):237-50. PubMed ID: 21789137
[TBL] [Abstract][Full Text] [Related]
29. Patched-2 functions to limit Patched-1 deficient skin cancer growth.
Veenstra VL; Dingjan I; Waasdorp C; Damhofer H; van der Wal AC; van Laarhoven HW; Medema JP; Bijlsma MF
Cell Oncol (Dordr); 2018 Aug; 41(4):427-437. PubMed ID: 29869097
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors.
Bhattarai D; Jung JH; Han S; Lee H; Oh SJ; Ko HW; Lee K
Eur J Med Chem; 2017 Jan; 125():1036-1050. PubMed ID: 27810591
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters.
Chandra V; Das T; Gulati P; Biswas NK; Rote S; Chatterjee U; Ghosh SN; Deb S; Saha SK; Chowdhury AK; Ghosh S; Rudin CM; Mukherjee A; Basu A; Dhara S
PLoS One; 2015; 10(3):e0116390. PubMed ID: 25775002
[TBL] [Abstract][Full Text] [Related]
32. Hedgehog pathway as a drug target: Smoothened inhibitors in development.
Lin TL; Matsui W
Onco Targets Ther; 2012; 5():47-58. PubMed ID: 22500124
[TBL] [Abstract][Full Text] [Related]
33. Hedgehog inhibition as an anti-cancer strategy.
Raju GP; Pham D
Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
[TBL] [Abstract][Full Text] [Related]
34. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
Makinodan E; Marneros AG
Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
[TBL] [Abstract][Full Text] [Related]
36. Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation.
Malatesta M; Steinhauer C; Mohammad F; Pandey DP; Squatrito M; Helin K
Cancer Res; 2013 Oct; 73(20):6323-33. PubMed ID: 23943798
[TBL] [Abstract][Full Text] [Related]
37. NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations.
Zhao J; Quan H; Xie C; Lou L
Pharmacol Res Perspect; 2014 Jun; 2(3):e00043. PubMed ID: 25505589
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma.
Cucchi D; Occhione MA; Gulino A; De Smaele E
J Exp Pharmacol; 2012; 4():173-85. PubMed ID: 27186130
[TBL] [Abstract][Full Text] [Related]
39. Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.
Chen H; Wang J; Yang H; Chen D; Li P
Oncol Lett; 2016 Oct; 12(4):2664-2673. PubMed ID: 27698840
[TBL] [Abstract][Full Text] [Related]
40. Identification of Nedd4 as a novel regulator in Hedgehog signaling.
Luo QF; Chen W; Zhang ST
Chin Med J (Engl); 2012 Nov; 125(21):3851-5. PubMed ID: 23106887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
